Current Research Studies - Heart & Vascular

The following list contains clinical studies in which the OSF HealthCare Cardiovascular Institute is enrolling patients.

For questions or to enroll, please contact our research staff at (309) 589-1930 in the Peoria area and (815) 395-9181 in Rockford.

Currently Enrolling - Peoria Area

  • UPSTREAM - Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Acute Coronary Syndrome: An ED-Based Clinical Registry

  • Summary: An ED-Based clinical registry evaluating the utilization of Ticagrelor in the upstream setting for Non-ST-Segment Elevation Acute Coronary Syndrome.

    Investigator: Sudhir Mungee

    Location: OSF HealthCare Cardiovascular Institute, Peoria, Illinois

    ClinicalTrials.gov: NCT02271022

    Contact: Stephanie Hillis, (309) 589-1934, stephanie.j.hillis@osfhealthcare.org

  • PRESERVED HF - Effects of dapagliflozin on biomarkers, symptoms and functional status in patients with Type 2 diabetes or pre-diabetes, and PRESERVED ejection fraction Heart Failure

  • Summary: A study to evaluate the effects of Dapagliflozin on biomarkers, symptoms and functional status in patients with Type II Diabetes or pre-diabetes, and preserved Ejection Fraction Heart Failure.

    Investigator: Barry Clemson

    Location: OSF HealthCare Cardiovascular Institute, Peoria, Illinois

    ClinicalTrials.gov: NCT03030235

    Contact: Stephanie Hillis, (309) 589-1934, stephanie.j.hillis@osfhealthcare.org

Currently Enrolling - Rockford Area

Peripheral Artery Disease (PAD)

  • GORE ISR: Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis in the Superficial Femoral Artery

  • Summary: A Clinical trial for patients who have already had stents in the legs and are experiencing reoccurring symptoms of PAD.

    Investigator: Asad Sheikh

    Location: OSF HealthCare Cardiovascular Institute, Rockford, Illinois

    ClinicalTrials.gov: NCT02542267

    Contact: Stephanie Hillis, (309) 589-1934, stephanie.j.hillis@osfhealthcare.org

  • PRESERVE-Zenith® Iliac Branch Clinical Study-Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation (Pivotal)

  • Summary: A Clinical trial for patients with an iliac aneurysm needing treatment.

    Investigator: David Cable

    Location: OSF HealthCare Cardiovascular Institute, Rockford, Illinois

    ClinicalTrials.gov: NCT02571907

    Contact: Ronak Patel, 815-398-3000, ronak.s.patel@osfhealthcare.org

Follow-Up Only - Peoria Area

  • IMPERIAL - A randomIzed trial coMParing the ELUVIA™ dRug-elutIng stent versus Zilver® PTX® stent for treatment of superficiAL femoral and/or proximal popliteal arteries

  • Summary: A randomized trial comparing the ELUVIA™ drug-elutIng stent versus Zilver® PTX® stent for treatment of superficial femoral and/or proximal popliteal arteries.

    Investigator: John Rashid

    Location: OSF HealthCare Cardiovascular Institute, Peoria, Illinois

    Contact: Stephanie Hillis, (309) 589-1934, stephanie.j.hillis@osfhealthcare.org